Making a statement to reporters on the sidelines of a Wednesday Cabinet meeting about Iran’s export of radiopharmaceuticals, Eslami said that scientists in the AEOI have made considerable efforts to turn Iran into one of the prominent producers and distributors of radiopharmaceuticals in the world.
He said Iran resumed exports of radiopharmaceuticals, which are mostly used for cancer treatment, to nine countries around the world after an easing of the COVID-19 pandemic last year.
The top official added that radiopharmaceuticals manufactured in Iran are more effective in comparison with other international brands, adding that researchers in the country will continue with efforts to further improve the effectiveness of the drugs.
Your Comment